178 related articles for article (PubMed ID: 36119026)
1. The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.
George PJ; Marches R; Nehar-Belaid D; Banchereau J; Lustigman S
Front Immunol; 2022; 13():961094. PubMed ID: 36119026
[No Abstract] [Full Text] [Related]
2. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
3. Surface immunogenic protein from Streptococcus agalactiae and
Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli maltose-binding protein (MBP) activates mouse Th1 through TLR2-mediated MyD88-dependent pathway and TLR4-mediated TRIF-dependent pathway.
Liu G; Zhang Y; Zhang N; Ni W; Jie J; Jiang L; Tai G
Int Immunopharmacol; 2017 Sep; 50():338-344. PubMed ID: 28750349
[TBL] [Abstract][Full Text] [Related]
5. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
[TBL] [Abstract][Full Text] [Related]
6. TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion.
Gandhapudi SK; Chilton PM; Mitchell TC
PLoS One; 2013; 8(2):e56855. PubMed ID: 23457630
[TBL] [Abstract][Full Text] [Related]
7. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
8. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4
Jain S; George PJ; Deng W; Koussa J; Parkhouse K; Hensley SE; Jiang J; Lu J; Liu Z; Wei J; Zhan B; Bottazzi ME; Shen H; Lustigman S
Vaccine; 2018 Jun; 36(25):3650-3665. PubMed ID: 29764680
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.
Planès R; Ben Haij N; Leghmari K; Serrero M; BenMohamed L; Bahraoui E
J Virol; 2016 Jul; 90(13):5886-5898. PubMed ID: 27053552
[TBL] [Abstract][Full Text] [Related]
11. TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.
Gaddis DE; Michalek SM; Katz J
J Immunol; 2011 May; 186(10):5772-83. PubMed ID: 21498664
[TBL] [Abstract][Full Text] [Related]
12. DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4.
Tanaka T; Legat A; Adam E; Steuve J; Gatot JS; Vandenbranden M; Ulianov L; Lonez C; Ruysschaert JM; Muraille E; Tuynder M; Goldman M; Jacquet A
Eur J Immunol; 2008 May; 38(5):1351-7. PubMed ID: 18389479
[TBL] [Abstract][Full Text] [Related]
13. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
14. Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist.
Bowen WS; Minns LA; Johnson DA; Mitchell TC; Hutton MM; Evans JT
Sci Signal; 2012 Feb; 5(211):ra13. PubMed ID: 22337809
[TBL] [Abstract][Full Text] [Related]
15. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.
Cekic C; Casella CR; Eaves CA; Matsuzawa A; Ichijo H; Mitchell TC
J Biol Chem; 2009 Nov; 284(46):31982-91. PubMed ID: 19759006
[TBL] [Abstract][Full Text] [Related]
17. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
18. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
19. TLR4-mediated activation of dendritic cells by the heat shock protein DnaK from Francisella tularensis.
Ashtekar AR; Zhang P; Katz J; Deivanayagam CC; Rallabhandi P; Vogel SN; Michalek SM
J Leukoc Biol; 2008 Dec; 84(6):1434-46. PubMed ID: 18708593
[TBL] [Abstract][Full Text] [Related]
20. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W
Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
